KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dillard'S (DDS) Cash & Equivalents (2016 - 2025)

Dillard'S (DDS) has disclosed Cash & Equivalents for 17 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 17.22% year-over-year to $1.1 billion, compared with a TTM value of $1.1 billion through Nov 2025, up 17.22%, and an annual FY2025 reading of $717.9 million, down 11.19% over the prior year.
  • Cash & Equivalents was $1.1 billion for Q4 2025 at Dillard'S, up from $1.0 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.1 billion in Q4 2025 and bottomed at $360.3 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $765.9 million, with a median of $791.3 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents surged 913.88% in 2021, then dropped 26.38% in 2022.
  • Year by year, Cash & Equivalents stood at $619.7 million in 2021, then fell by 14.04% to $532.7 million in 2022, then surged by 58.06% to $842.0 million in 2023, then grew by 16.44% to $980.4 million in 2024, then grew by 17.22% to $1.1 billion in 2025.
  • Business Quant data shows Cash & Equivalents for DDS at $1.1 billion in Q4 2025, $1.0 billion in Q3 2025, and $900.5 million in Q2 2025.